Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

16.90
Delayed Data
As of 3:59pm ET
 +0.95 / +5.96%
Today’s Change
7.18
Today|||52-Week Range
16.90
+39.09%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 21.00, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +24.26% increase from the last price of 16.90.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.61
Sales
$5.9M
Reporting Date
Apr 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -478.13%
 
 
 
 
 
 
Growthannually -730.77%
 
 
 
 
 
 

Sales

Growthquarterly -82.27%
 
 
 
 
 
 
Growthannually -71.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.